Infusio

The core of Infusio's business is its proprietary "Infusio Concept," a five-step integrative approach designed to rebuild the immune system and address the root causes of illness. This methodology includes immune modulation, cellular optimization, detoxification, disease-specific treatments, and mind-body medicine. The company serves patients from around the world who are often seeking alternatives to conventional treatments, including those with autoimmune disorders, neurological conditions, and cancer. Revenue is generated directly from patients for these treatment programs, which can be intensive, multi-week regimens. As treatments are often not covered by insurance, the company states it aims to keep prices as low as possible.

Infusio's primary service is its Cell Therapy Program, which utilizes various forms of stem cell-based therapies. A key offering is Stromal Vascular Fraction (SVF) therapy, which involves harvesting stem cells from a patient's own fat tissue. This concentrate of mesenchymal stem cells, exosomes, and other factors is reintroduced intravenously to regulate the immune response, reduce inflammation, and repair tissue damage. The company also offers treatments using exosomes derived from placental mesenchymal stem cells, particularly for patients who may be severely immune-deficient. Beyond cell therapies, Infusio provides a range of services including IV therapies with vitamins and minerals, regional hyperthermia for cancer, and ACT immunotherapy. It operates clinics in locations including Frankfurt, Germany, with a patient base from Europe, the US, and Asia.